{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:53:50Z","timestamp":1793393630298,"version":"4.5.0"},"reference-count":320,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bcp.2021.114809","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T20:17:10Z","timestamp":1634674630000},"page":"114809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Pathogenic mitochondrial dysfunction and metabolic abnormalities"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-811X","authenticated-orcid":false,"given":"Walter H.","family":"Moos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-3478","authenticated-orcid":false,"given":"Douglas V.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis P.","family":"Glavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-6038","authenticated-orcid":false,"given":"David N.","family":"Harpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kamperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iphigenia","family":"Kanara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Kodukula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios N.","family":"Mavrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pernokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pernokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-3881","authenticated-orcid":false,"given":"Carl A.","family":"Pinkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney R.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosta","family":"Steliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-4812","authenticated-orcid":false,"given":"Constantin","family":"Tamvakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-328X","authenticated-orcid":false,"given":"Konstantina","family":"Sampani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114809_b0005","series-title":"A dictionary of classical mythology","author":"Grimal","year":"1986"},{"key":"10.1016\/j.bcp.2021.114809_b0010","series-title":"The Invention of Medicine: From Homer to Hippocrates","author":"Fox","year":"2020"},{"key":"10.1016\/j.bcp.2021.114809_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humic.2017.05.004","article-title":"History of medicine: Origin of the term microbiome and why it matters","volume":"4","author":"Prescott","year":"2017","journal-title":"Hum Microbiome J."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcmg.2021.01.003","article-title":"Getting down with diet and exercise for coronary artery disease treatment: Insights from the DISCO-CT study","volume":"14","author":"Jaffer","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0025","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/nu13051728","article-title":"Exploring the role and potential of probiotics in the field of mental health: Major depressive disorder","volume":"13","author":"Johnson","year":"2021","journal-title":"Nutrients."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(21)00146-7","article-title":"First, do no harm","volume":"9","author":"Thorley","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"105099","key":"10.1016\/j.bcp.2021.114809_b0035","article-title":"Brain on food: The neuroepigenetics of nutrition","volume":"149","author":"Vaziri","year":"2021","journal-title":"Neurochem Int."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2021.114809_b0040","article-title":"Mitochondrial dysfunction in age-related metabolic disorders","volume":"20","author":"Natarajan","year":"2020","journal-title":"Proteomics."},{"key":"10.1016\/j.bcp.2021.114809_b0045","doi-asserted-by":"crossref","unstructured":"Rossmann MP, Dubois SM, Agarwal S, Zon LI. Mitochondrial function in development and disease. Dis Model Mech [Internet]. 2021;14(6). Available from: http:\/\/dx.doi.org\/10.1242\/dmm.048912.","DOI":"10.1242\/dmm.048912"},{"issue":"16","key":"10.1016\/j.bcp.2021.114809_b0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/ars.2020.8132","article-title":"Are reactive sulfur species the new reactive oxygen species?","volume":"33","author":"Olson","year":"2020","journal-title":"Antioxid Redox Signal."},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/biomedicines8110526","article-title":"Mitochondria at work: New insights into regulation and dysregulation of cellular energy supply and metabolism","volume":"8","author":"Schirrmacher","year":"2020","journal-title":"Biomedicines."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Mitochondrial function as a therapeutic target in heart failure: Expert consensus document","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacbts.2019.03.003","article-title":"Targeting mitochondrial function in heart failure: Makes sense but will it work?","volume":"4","author":"Khan","year":"2019","journal-title":"JACC Basic Transl Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0070","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/ijms22020614","article-title":"Mitochondrial dysfunction and heart disease: Critical appraisal of an overlooked association","volume":"22","author":"Bisaccia","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b0075","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jama.2021.8789","article-title":"Ketone body supplementation-A potential new approach for heart disease","volume":"326","author":"Abbasi","year":"2021","journal-title":"JAMA."},{"issue":"e11485","key":"10.1016\/j.bcp.2021.114809_b0085","article-title":"Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?","volume":"9","author":"Bowman","year":"2021","journal-title":"PeerJ."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166208","article-title":"Mitochondrial function, dynamics and quality control in the pathophysiology of HFpEF","volume":"1867","author":"Del Campo","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0095","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41418-020-00729-0","article-title":"Heart failure-emerging roles for the mitochondrial pyruvate carrier","volume":"28","author":"Fernandez-Caggiano","year":"2021","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0100","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.3390\/ijms22147392","article-title":"Calcium and heart failure: How did we get here and where are we going?","volume":"22","author":"Siri-Angkul","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"17","key":"10.1016\/j.bcp.2021.114809_b0105","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death","volume":"143","author":"Umapathi","year":"2021","journal-title":"Circulation."},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0110","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3390\/ijms22147349","article-title":"Skeletal muscle mitochondria dysfunction in genetic neuromuscular disorders with cardiac phenotype","volume":"22","author":"Ignatieva","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0115","first-page":"60","article-title":"The role of oxidative stress in cardiovascular aging and cardiovascular diseases","volume":"11","author":"Izzo","year":"2021","journal-title":"Life (Basel)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.21732","article-title":"Mitochondrial dysfunction in cardiovascular disease: Current status of translational research\/clinical and therapeutic implications","volume":"41","author":"Manolis","year":"2021","journal-title":"Med Res Rev."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/dna.2021.0087","article-title":"Extracellular mitochondrial components and effects on cardiovascular disease","volume":"40","author":"Xu","year":"2021","journal-title":"DNA Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2019.07.009","article-title":"Targeting the mitochondria in heart failure: A translational perspective","volume":"5","author":"Sabbah","year":"2020","journal-title":"JACC Basic Transl Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/cells10020420","article-title":"Potential treatment of lysosomal storage disease through modulation of the mitochondrial-lysosomal axis","volume":"10","author":"Kuk","year":"2021","journal-title":"Cells."},{"issue":"108689","key":"10.1016\/j.bcp.2021.114809_b0145","article-title":"Clinical features of mtDNA-related syndromes in adulthood","volume":"697","author":"Montano","year":"2021","journal-title":"Arch Biochem Biophys."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","article-title":"Mitochondrial disease in adults: recent advances and future promise","volume":"20","author":"Ng","year":"2021","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jimd.12281","article-title":"Moving towards clinical trials for mitochondrial diseases","volume":"44","author":"Pitceathly","year":"2021","journal-title":"J Inherit Metab Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cell.2020.02.051","article-title":"Mitochondrial diseases: Hope for the future","volume":"181","author":"Russell","year":"2020","journal-title":"Cell."},{"issue":"103244","key":"10.1016\/j.bcp.2021.114809_b0165","article-title":"Pharmacological advances in mitochondrial therapy","volume":"65","author":"Singh","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrm.2017.66","article-title":"Mitochondrial diseases: the contribution of organelle stress responses to pathology","volume":"19","author":"Suomalainen","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jimd.12104","article-title":"Recent advances in understanding the molecular genetic basis of mitochondrial disease","volume":"43","author":"Thompson","year":"2020","journal-title":"J Inherit Metab Dis."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40291-020-00510-6","article-title":"Current and emerging clinical treatment in mitochondrial disease","volume":"25","author":"Tinker","year":"2021","journal-title":"Mol Diagn Ther."},{"issue":"30","key":"10.1016\/j.bcp.2021.114809_b0185","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/s41388-021-01850-1","article-title":"FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat Metab."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0195","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2020.04.002","article-title":"Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK\/PGC-1\u03b1 pathway in skeletal muscle","volume":"526","author":"Guo","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.bcp.2021.114809_b0200","article-title":"FGF, mechanism of action, role in Parkinson\u2019s disease, and therapeutics","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/biores.2020.0004","article-title":"Klotho pathways, myelination disorders, neurodegenerative diseases, and epigenetic drugs","volume":"9","author":"Moos","year":"2020","journal-title":"Biores Open Access."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MNH.0000000000000467","article-title":"Fibroblast growth factor 23 and \u03b1-Klotho co-dependent and independent functions","volume":"28","author":"Quarles","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"50","key":"10.1016\/j.bcp.2021.114809_b0215","doi-asserted-by":"crossref","first-page":"31800","DOI":"10.1073\/pnas.2018554117","article-title":"FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with \u03b1-Klotho","volume":"117","author":"Suzuki","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0220","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.bbadis.2018.08.008","article-title":"Endothelial cell senescence in aging-related vascular dysfunction","volume":"1865","author":"Jia","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0225","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","article-title":"Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19","volume":"320","author":"Ajaz","year":"2021","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.bcp.2021.114809_b0230","unstructured":"Naqvi SMAS, Farhan A, Hua Y. Therapeutic potential of FGF21 in atrial fibrillation through regulating atrial metabolic remodeling. GJM.020101 [Internet]. Naturescholars.com. [cited 2021 Sep 28]. Available from: http:\/\/naturescholars.com\/gjm.020101."},{"issue":"49","key":"10.1016\/j.bcp.2021.114809_b0235","doi-asserted-by":"crossref","first-page":"31259","DOI":"10.1073\/pnas.2017129117","article-title":"Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease","volume":"117","author":"Yueh","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"525","key":"10.1016\/j.bcp.2021.114809_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay5186","article-title":"Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy","volume":"12","author":"Hernandez","year":"2020","journal-title":"Sci Transl Med."},{"issue":"110796","key":"10.1016\/j.bcp.2021.114809_b0245","article-title":"Mitochondrial uncoupling and longevity \u2013 A role for mitokines?","volume":"130","author":"Klaus","year":"2020","journal-title":"Exp Gerontol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114809_b0250","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.3390\/ijms20194692","article-title":"Fibroblast Growth Factor 21 and the adaptive response to nutritional challenges","volume":"20","author":"Mart\u00ednez-Garza","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b0255","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fphys.2019.00419","article-title":"FGF21 as modulator of metabolism in health and disease","volume":"10","author":"Tezze","year":"2019","journal-title":"Front Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b0260","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1210\/me.2015-1155","article-title":"Minireview: Roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases","volume":"29","author":"Zhang","year":"2015","journal-title":"Mol Endocrinol."},{"issue":"13","key":"10.1016\/j.bcp.2021.114809_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109331","article-title":"FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes","volume":"35","author":"Abu-Odeh","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","author":"Kuro-O","year":"2019","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12882-018-1094-z","article-title":"The role of klotho in chronic kidney disease","volume":"19","author":"Zou","year":"2018","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11684-019-0711-y","article-title":"The FGF metabolic axis","volume":"13","author":"Li","year":"2019","journal-title":"Front Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0285","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10741-019-09809-x","article-title":"A review of fibroblast growth factor 21 in diabetic cardiomyopathy","volume":"24","author":"Zhang","year":"2019","journal-title":"Heart Fail Rev."},{"issue":"110439","key":"10.1016\/j.bcp.2021.114809_b0290","article-title":"FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress","volume":"129","author":"Kang","year":"2020","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/ijms22010091","article-title":"The interplay between mitochondrial morphology and myomitokines in aging sarcopenia","volume":"22","author":"Romanello","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b0300","doi-asserted-by":"crossref","unstructured":"Tan JX, Finkel T. Mitochondria as intracellular signaling platforms in health and disease. J Cell Biol [Internet]. 2020;219(5). Available from: http:\/\/dx.doi.org\/10.1083\/jcb.202002179.","DOI":"10.1083\/jcb.202002179"},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0305","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cmet.2019.08.019","article-title":"Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions","volume":"30","author":"Forsstr\u00f6m","year":"2019","journal-title":"Cell Metab."},{"issue":"106050","key":"10.1016\/j.bcp.2021.114809_b0310","article-title":"The ketogenic diet as a therapeutic intervention strategy in mitochondrial disease","volume":"138","author":"Qu","year":"2021","journal-title":"Int J Biochem Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0315","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/ijms20061400","article-title":"Normal FGF-21-serum levels in patients with carnitine palmitoyltransferase II (CPT II) deficiency","volume":"20","author":"Scholle","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"22","key":"10.1016\/j.bcp.2021.114809_b0320","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders","volume":"87","author":"Lehtonen","year":"2016","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0325","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jcsm.12409","article-title":"Fibroblast growth factor 21 controls mitophagy and muscle mass","volume":"10","author":"Oost","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0330","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.3390\/ijms22083903","article-title":"Mitophagy in human diseases","volume":"22","author":"Doblado","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"16","key":"10.1016\/j.bcp.2021.114809_b0335","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in human diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bcp.2021.114809_b0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ebiom.2016.10.034","article-title":"Therapeutic targeting of autophagy","volume":"14","author":"Towers","year":"2016","journal-title":"EBioMedicine."},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0345","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.devcel.2021.06.003","article-title":"Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy","volume":"56","author":"Towers","year":"2021","journal-title":"Dev Cell."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0350","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41418-019-0480-9","article-title":"Autophagy and disease: unanswered questions","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Death Differ."},{"issue":"6454","key":"10.1016\/j.bcp.2021.114809_b0355","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw9855","article-title":"Mitochondria-Striking a balance between host and endosymbiont","volume":"365","author":"Youle","year":"2019","journal-title":"Science."},{"issue":"101191","key":"10.1016\/j.bcp.2021.114809_b0360","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res Rev."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/ars.2020.8058","article-title":"Mitochondrial reactive oxygen species and mitophagy: A complex and nuanced relationship","volume":"34","author":"Schofield","year":"2021","journal-title":"Antioxid Redox Signal."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b0370","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41590-020-00813-0","article-title":"A new neutrophil subset promotes CNS neuron survival and axon regeneration","volume":"21","author":"Sas","year":"2020","journal-title":"Nat Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b0375","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.cell.2021.04.027","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell."},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0380","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.devcel.2021.07.001","article-title":"Move it to lose it: Mitocytosis expels damaged mitochondria","volume":"56","author":"Mehra","year":"2021","journal-title":"Dev Cell."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b0385","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1089\/ars.2019.8013","article-title":"Mitophagy and its contribution to metabolic and aging-associated disorders","volume":"32","author":"Liu","year":"2020","journal-title":"Antioxid Redox Signal."},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0390","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.devcel.2021.06.022","article-title":"MDVs to the rescue: How autophagy-deficient cancer cells adapt to defective mitophagy","volume":"56","author":"Poillet-Perez","year":"2021","journal-title":"Dev Cell."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0395","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1074\/jbc.M113.521641","article-title":"GCN5-like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy","volume":"289","author":"Scott","year":"2014","journal-title":"J Biol Chem."},{"issue":"24","key":"10.1016\/j.bcp.2021.114809_b0400","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1007\/s00018-016-2282-2","article-title":"Mitochondrial cAMP signaling","volume":"73","author":"Zhang","year":"2016","journal-title":"Cell Mol Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu Rev Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.12655","article-title":"Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment","volume":"23","author":"Golpich","year":"2017","journal-title":"CNS Neurosci Ther."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0415","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/MCB.01483-13","article-title":"SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress","volume":"34","author":"Samant","year":"2014","journal-title":"Mol Cell Biol."},{"issue":"6489","key":"10.1016\/j.bcp.2021.114809_b0420","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: From mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0425","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/biores.2016.0010","article-title":"Microbiota and neurological disorders: A gut feeling","volume":"5","author":"Moos","year":"2016","journal-title":"Biores Open Access."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0430","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/biores.2017.0036","article-title":"Epigenetic treatment of neurodegenerative ophthalmic disorders: An eye toward the future","volume":"6","author":"Moos","year":"2017","journal-title":"Biores Open Access."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b0435","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","article-title":"Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association","volume":"118","author":"Murphy","year":"2016","journal-title":"Circ Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0440","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13590","article-title":"Mitochondrial quality surveillance as a therapeutic target in myocardial infarction","volume":"231","author":"Zhu","year":"2021","journal-title":"Acta Physiol (Oxf)."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0445","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s00018-021-03804-y","article-title":"CMLS forum reviews: mitochondrial damage control","volume":"78","author":"Hamacher-Brady","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.bcp.2021.114809_b0450","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.mito.2021.06.005","article-title":"A hitchhiker\u2019s guide to mitochondrial quantification","volume":"59","author":"Hemel","year":"2021","journal-title":"Mitochondrion."},{"key":"10.1016\/j.bcp.2021.114809_b0455","doi-asserted-by":"crossref","unstructured":"Ravanelli S, den Brave F, Hoppe T. Mitochondrial quality control governed by ubiquitin. Front Cell Dev Biol [Internet]. 2020;8. Available from: http:\/\/dx.doi.org\/10.3389\/fcell.2020.00270.","DOI":"10.3389\/fcell.2020.00270"},{"issue":"14","key":"10.1016\/j.bcp.2021.114809_b0460","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1113\/JP279376","article-title":"The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction","volume":"599","author":"Federico","year":"2021","journal-title":"J Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0465","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/cells10030537","article-title":"Cell death and inflammation: The role of mitochondria in health and disease","volume":"10","author":"Picca","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2021.114809_b0470","doi-asserted-by":"crossref","unstructured":"Amin AM. The metabolic signatures of cardiometabolic diseases: Does the shared metabotype offer new therapeutic targets? Lifestyle Medicine [Internet]. 2021;2(1). Available from: http:\/\/dx.doi.org\/10.1002\/lim2.25.","DOI":"10.1002\/lim2.25"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0475","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40265-020-01428-3","article-title":"Therapeutic options in hereditary optic neuropathies","volume":"81","author":"Amore","year":"2021","journal-title":"Drugs."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0480","first-page":"288","article-title":"Improvement of platelet respiration by cell-permeable succinate in diabetic patients treated with statins","volume":"11","author":"Avram","year":"2021","journal-title":"Life (Basel)."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jimd.12319","article-title":"The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery","volume":"44","author":"Falk","year":"2021","journal-title":"J Inherit Metab Dis."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0490","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.10.8.4","article-title":"The present and future of mitochondrial-based therapeutics for eye disease","volume":"10","author":"Ji","year":"2021","journal-title":"Transl Vis Sci Technol."},{"issue":"113888","key":"10.1016\/j.bcp.2021.114809_b0495","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0500","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1039\/D1MD00113B","article-title":"The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health","volume":"12","author":"Lee","year":"2021","journal-title":"RSC Med Chem."},{"key":"10.1016\/j.bcp.2021.114809_b0505","doi-asserted-by":"crossref","unstructured":"Murphy AJ, Febbraio MA. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future. Nat Rev Immunol [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41577-021-00580-5.","DOI":"10.1038\/s41577-021-00580-5"},{"key":"10.1016\/j.bcp.2021.114809_b0510","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semcdb.2021.02.006","article-title":"Aging: All roads lead to mitochondria","volume":"116","author":"Son","year":"2021","journal-title":"Semin Cell Dev Biol."},{"key":"10.1016\/j.bcp.2021.114809_b0515","doi-asserted-by":"crossref","unstructured":"Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. A guide to interrogating immunometabolism. Nat Rev Immunol [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41577-021-00529-8.","DOI":"10.1038\/s41577-021-00529-8"},{"issue":"101988","key":"10.1016\/j.bcp.2021.114809_b0520","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165967","article-title":"Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches","volume":"1867","author":"Hebert","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"105050","key":"10.1016\/j.bcp.2021.114809_b0530","article-title":"How the brain fights fatty acids\u2019 toxicity","volume":"148","author":"Sch\u00f6nfeld","year":"2021","journal-title":"Neurochem Int."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0535","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/ars.2020.8070","article-title":"Mitochondria-targeted therapeutics for Alzheimer\u2019s disease: The good, the bad, the potential","volume":"34","author":"Mi","year":"2021","journal-title":"Antioxid Redox Signal."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0540","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0545","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cmet.2020.11.008","article-title":"Intercellular mitochondria transfer to macrophages regulates white adipose tissue homeostasis and is impaired in obesity","volume":"33","author":"Brestoff","year":"2021","journal-title":"Cell Metab."},{"issue":"101039","key":"10.1016\/j.bcp.2021.114809_b0550","article-title":"Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury","volume":"59","author":"Gollihue","year":"2020","journal-title":"Ageing Res Rev."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2021.114809_b0555","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10495-021-01661-5","article-title":"New insights into targeting mitochondria in ischemic injury","volume":"26","author":"Jia","year":"2021","journal-title":"Apoptosis."},{"key":"10.1016\/j.bcp.2021.114809_b0560","doi-asserted-by":"crossref","unstructured":"van der Vlist M, Raoof R, Willemen HLDM, Prado J, Versteeg S, Gil CM, et al. Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain [Internet]. bioRxiv 2020. Available from: http:\/\/dx.doi.org\/10.1101\/2020.02.12.940445.","DOI":"10.1101\/2020.02.12.940445"},{"key":"10.1016\/j.bcp.2021.114809_b0565","doi-asserted-by":"crossref","unstructured":"Nag TC. Pathogenic mechanisms contributing to the vulnerability of aging human photoreceptor cells. Eye [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41433-021-01602-1.","DOI":"10.1038\/s41433-021-01602-1"},{"key":"10.1016\/j.bcp.2021.114809_b0570","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653522","article-title":"The role of MicroRNAs in mitochondria-mediated eye diseases","volume":"9","author":"Carrella","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"100881","key":"10.1016\/j.bcp.2021.114809_b0575","article-title":"Retinal energy metabolism in health and glaucoma","volume":"81","author":"Casson","year":"2021","journal-title":"Prog Retin Eye Res."},{"key":"10.1016\/j.bcp.2021.114809_b0580","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000618","article-title":"Fatty acid oxidation and photoreceptor metabolic needs","volume":"62","author":"Fu","year":"2021","journal-title":"J Lipid Res."},{"issue":"100941","key":"10.1016\/j.bcp.2021.114809_b0585","article-title":"Uncoupling proteins in the mitochondrial defense against oxidative stress","volume":"83","author":"Hass","year":"2021","journal-title":"Prog Retin Eye Res."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0590","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/ijms22073689","article-title":"Energy metabolism in the inner retina in health and glaucoma","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"108498","key":"10.1016\/j.bcp.2021.114809_b0595","article-title":"Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy","volume":"187","author":"Rolev","year":"2021","journal-title":"Neuropharmacology."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0600","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.gendis.2020.01.003","article-title":"Does epigenetics have a role in age related macular degeneration and diabetic retinopathy?","volume":"8","author":"Devi","year":"2020","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0605","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/clinem\/dgaa921","article-title":"Association of cognitive function and retinal neural and vascular structure in type 1 diabetes","volume":"106","author":"Fickweiler","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"100860","key":"10.1016\/j.bcp.2021.114809_b0610","article-title":"Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases","volume":"79","author":"Gorbatyuk","year":"2020","journal-title":"Prog Retin Eye Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0615","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.survophthal.2019.11.001","article-title":"Mitochondrial disorders and the eye","volume":"65","author":"Kisilevsky","year":"2020","journal-title":"Surv Ophthalmol."},{"issue":"100849","key":"10.1016\/j.bcp.2021.114809_b0620","article-title":"Extracellular vesicle therapy for retinal diseases","volume":"79","author":"Mead","year":"2020","journal-title":"Prog Retin Eye Res."},{"issue":"100919","key":"10.1016\/j.bcp.2021.114809_b0625","article-title":"Photoreceptor cells and RPE contribute to the development of diabetic retinopathy","volume":"83","author":"Tonade","year":"2021","journal-title":"Prog Retin Eye Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0630","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMcp2102061","article-title":"Age-related macular degeneration","volume":"385","author":"Apte","year":"2021","journal-title":"N Engl J Med."},{"issue":"100858","key":"10.1016\/j.bcp.2021.114809_b0635","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2021","journal-title":"Prog Retin Eye Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0640","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and Macrovascular Complications of Diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin Diabetes."},{"key":"10.1016\/j.bcp.2021.114809_b0645","doi-asserted-by":"crossref","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157(107843):107843.","DOI":"10.1016\/j.diabres.2019.107843"},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b0650","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/jcbfm.2013.145","article-title":"Functional hyperemia and mechanisms of neurovascular coupling in the retinal vasculature","volume":"33","author":"Newman","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1016\/j.bcp.2021.114809_b0655","doi-asserted-by":"crossref","unstructured":"Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight [Internet]. 2016;1(15). Available from: http:\/\/dx.doi.org\/10.1172\/jci.insight.86976.","DOI":"10.1172\/jci.insight.86976"},{"key":"10.1016\/j.bcp.2021.114809_b0660","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2014.12.001","article-title":"The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding","volume":"45","author":"Zhang","year":"2015","journal-title":"Prog Retin Eye Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0665","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1566524019666191113120828","article-title":"Mass spectrometric analysis of L-carnitine and its esters: Potential biomarkers of disturbances in carnitine homeostasis","volume":"20","author":"Bene","year":"2020","journal-title":"Curr Mol Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0670","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10522-021-09910-5","article-title":"Aging and age-related diseases: from mechanisms to therapeutic strategies","volume":"22","author":"Li","year":"2021","journal-title":"Biogerontology."},{"key":"10.1016\/j.bcp.2021.114809_b0675","article-title":"L-carnitine and acylcarnitines: Mitochondrial biomarkers for precision medicine","author":"McCann","year":"202111151","journal-title":"Metabolites."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109488","article-title":"Excess dietary carbohydrate affects mitochondrial integrity as observed in brown adipose tissue","volume":"36","author":"Waldhart","year":"2021","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b0685","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/antiox9090897","article-title":"Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: Therapeutic effects of vitamin D","volume":"9","author":"de Las","year":"2020","journal-title":"Antioxidants (Basel)."},{"issue":"111147","key":"10.1016\/j.bcp.2021.114809_b0690","article-title":"Age-related mitochondrial dysfunction as a key factor in COVID-19 disease","volume":"142","author":"Fern\u00e1ndez-Ayala","year":"2020","journal-title":"Exp Gerontol."},{"key":"10.1016\/j.bcp.2021.114809_b0695","doi-asserted-by":"crossref","unstructured":"Li S, Ma F, Yokota T, Garcia G Jr, Palermo A, Wang Y, et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. JCI Insight [Internet]. 2021;6(2). Available from: http:\/\/dx.doi.org\/10.1172\/jci.insight.145027.","DOI":"10.1172\/jci.insight.145027"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0700","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/diseases9010017","article-title":"Involvement of oxidative stress and the innate immune system in SARS-CoV-2 infection","volume":"9","author":"Kozlov","year":"2021","journal-title":"Diseases."},{"key":"10.1016\/j.bcp.2021.114809_b0705","article-title":"Survival factors and metabolic pathogenesis in elderly patients (\u226565) with COVID-19: A multi-center study","volume":"7","author":"Mei","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.bcp.2021.114809_b0710","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clnesp.2021.06.011","article-title":"The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19","volume":"44","author":"Tsoukalas","year":"2021","journal-title":"Clin Nutr ESPEN."},{"issue":"101976","key":"10.1016\/j.bcp.2021.114809_b0715","article-title":"The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic","volume":"43","author":"Burtscher","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2021.114809_b0720","doi-asserted-by":"crossref","unstructured":"Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: In the cross fire of SARS-CoV-2 and immunity. iScience. 2020;23(10):101631.","DOI":"10.1016\/j.isci.2020.101631"},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0725","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/CS20200752","article-title":"ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders","volume":"135","author":"Cao","year":"2021","journal-title":"Clin Sci (Lond)."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b0730","first-page":"232","article-title":"Role of mitochondria in viral infections","volume":"11","author":"Elesela","year":"2021","journal-title":"Life (Basel)."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0735","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1109","article-title":"The rOX-stars of inflammation: links between the inflammasome and mitochondrial meltdown","volume":"9","author":"Holley","year":"2020","journal-title":"Clin Transl Immunology."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114809_b0740","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/08830185.2020.1840567","article-title":"How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?","volume":"40","author":"Kumar","year":"2021","journal-title":"Int Rev Immunol."},{"key":"10.1016\/j.bcp.2021.114809_b0745","article-title":"A review of the current status of clinical management of COVID-19 in the elderly","volume":"27","author":"Li","year":"2021","journal-title":"Med Sci Monit."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0750","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ddr.21366","article-title":"Epigenetic treatment of persistent viral infections: Epigenetic treatment of persistent viral infections","volume":"78","author":"Moos","year":"2017","journal-title":"Drug Dev Res."},{"key":"10.1016\/j.bcp.2021.114809_b0755","article-title":"Targeting immunometabolism to treat COVID-19","author":"O\u2019Carroll","year":"202111013","journal-title":"Immunother Adv."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0760","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/dna.2020.6453","article-title":"COVID-19: A mitochondrial perspective","volume":"40","author":"Prasun","year":"2021","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bcp.2021.114809_b0765","doi-asserted-by":"crossref","unstructured":"Sharma A, Kontodimas K, Bosmann M. The MAVS immune recognition pathway in viral infection and sepsis. Antioxid Redox Signal [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1089\/ars.2021.0167.","DOI":"10.1089\/ars.2021.0167"},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b0770","doi-asserted-by":"crossref","first-page":"C258","DOI":"10.1152\/ajpcell.00224.2020","article-title":"Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis","volume":"319","author":"Singh","year":"2020","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.bcp.2021.114809_b0775","doi-asserted-by":"crossref","unstructured":"Srinivasan K, Pandey A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology [Internet]. 2021. Available from: http:\/\/dx.doi.org\/10.22541\/au.161047974.41668545\/v1.","DOI":"10.22541\/au.161047974.41668545\/v1"},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0780","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tcb.2020.01.006","article-title":"Mitochondrial functions in infection and immunity","volume":"30","author":"Tiku","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2021.114809_b0785","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijbiomac.2021.07.013","article-title":"Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2","volume":"186","author":"Baral","year":"2021","journal-title":"Int J Biol Macromol."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2021.114809_b0790","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/hum.2021.052","article-title":"Current update on severe acute respiratory syndrome Coronavirus 2 vaccine development with a special emphasis on gene therapy viral vector design and construction for vaccination","volume":"32","author":"Bisgin","year":"2021","journal-title":"Hum Gene Ther."},{"key":"10.1016\/j.bcp.2021.114809_b0795","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.addr.2021.01.014","article-title":"SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?","volume":"172","author":"Chakraborty","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.bcp.2021.114809_b0800","doi-asserted-by":"crossref","unstructured":"Maeda DLNF, Tian D, Yu H, Dar N, Rajasekaran V, Meng S, et al. Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model. Proc Natl Acad Sci U S A [Internet]. 2021;118(18). Available from: http:\/\/dx.doi.org\/10.1073\/pnas.2025622118.","DOI":"10.1073\/pnas.2025622118"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0805","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/vaccines9010039","article-title":"A COVID-19 vaccine: Big strides come with big challenges","volume":"9","author":"Mellet","year":"2021","journal-title":"Vaccines (Basel)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0810","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drudis.2020.10.018","article-title":"Union is strength: antiviral and anti-inflammatory drugs for COVID-19","volume":"26","author":"Naveja","year":"2021","journal-title":"Drug Discov Today."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0815","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/biomedicines9060611","article-title":"SARS-CoV-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of SARS-CoV-2 variants","volume":"9","author":"Scialo","year":"2021","journal-title":"Biomedicines."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0820","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","article-title":"The success of SARS-CoV-2 vaccines and challenges ahead","volume":"29","author":"Subbarao","year":"2021","journal-title":"Cell Host Microbe."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0825","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acscentsci.1c00080","article-title":"Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19\/AZD1222 vaccine","volume":"7","author":"Watanabe","year":"2021","journal-title":"ACS Cent Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0830","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b0835","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCRESAHA.121.317997","article-title":"COVID-19 and cardiovascular disease: From bench to bedside: From bench to bedside","volume":"128","author":"Chung","year":"2021","journal-title":"Circ Res."},{"issue":"27","key":"10.1016\/j.bcp.2021.114809_b0840","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3032","article-title":"Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies","volume":"7","author":"Han","year":"2021","journal-title":"Sci Adv."},{"issue":"30","key":"10.1016\/j.bcp.2021.114809_b0845","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024302118","article-title":"Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay","volume":"118","author":"Jang","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bcp.2021.114809_b0850","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.addr.2021.01.002","article-title":"Nanocarrier vaccines for SARS-CoV-2","volume":"171","author":"Machhi","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.bcp.2021.114809_b0855","doi-asserted-by":"crossref","unstructured":"Scavone C, Mascolo A, Rafaniello C, Sportiello L, Trama U, Zoccoli A, et al. Therapeutic strategies to fight COVID-19: Which is the status artis? Br J Pharmacol [Internet]. 2021;(bph.15452). Available from: http:\/\/dx.doi.org\/10.1111\/bph.15452.","DOI":"10.22541\/au.161098712.28650241\/v1"},{"issue":"6554","key":"10.1016\/j.bcp.2021.114809_b0860","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.abi4708","article-title":"Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2","volume":"373","author":"Tummino","year":"2021","journal-title":"Science."},{"issue":"113584","key":"10.1016\/j.bcp.2021.114809_b0865","article-title":"Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies","volume":"222","author":"Vuong","year":"2021","journal-title":"Eur J Med Chem."},{"issue":"114296","key":"10.1016\/j.bcp.2021.114809_b0870","article-title":"Repurposing existing drugs for the treatment of COVID-19\/SARS-CoV-2 infection: A review describing drug mechanisms of action","volume":"183","author":"Yousefi","year":"2021","journal-title":"Biochem Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0875","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-020-0237-2","article-title":"A metabolic handbook for the COVID-19 pandemic","volume":"2","author":"Ayres","year":"2020","journal-title":"Nat Metab."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b0880","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrmicro1955","article-title":"Revisiting the host as a growth medium","volume":"6","author":"Brown","year":"2008","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.bcp.2021.114809_b0885","doi-asserted-by":"crossref","unstructured":"Cai Y, Kim DJ, Takahashi T, Broadhurst DI, Yan H, Ma S, et al. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci Signal. 2021;14(690):eabf8483.","DOI":"10.1126\/scisignal.abf8483"},{"key":"10.1016\/j.bcp.2021.114809_b0890","doi-asserted-by":"crossref","unstructured":"Pernas L. Cellular metabolism in the defense against microbes. J Cell Sci. 2021;134(5):jcs252023.","DOI":"10.1242\/jcs.252023"},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b0895","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/ijms21103544","article-title":"The role of lipid metabolism in COVID-19 virus infection and as a drug target","volume":"21","author":"Abu-Farha","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b0900","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.555039","article-title":"Regulation of angiotensin- converting enzyme 2 in obesity: Implications for COVID-19","volume":"11","author":"Al Heialy","year":"2020","journal-title":"Front Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2214","article-title":"Lipid-based therapies against SARS-CoV-2 infection","volume":"31","author":"Alketbi","year":"2021","journal-title":"Rev Med Virol."},{"issue":"101092","key":"10.1016\/j.bcp.2021.114809_b0910","article-title":"Dissecting lipid metabolism alterations in SARS-CoV-2","volume":"82","author":"Casari","year":"2021","journal-title":"Prog Lipid Res."},{"key":"10.1016\/j.bcp.2021.114809_b0915","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660490","article-title":"The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models","volume":"12","author":"Davies","year":"2021","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0920","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3748\/wjg.v27.i1.37","article-title":"Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review","volume":"27","author":"Koriem","year":"2021","journal-title":"World J Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b0925","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/v13010090","article-title":"The fatty acid lipid metabolism nexus in COVID-19","volume":"13","author":"Tanner","year":"2021","journal-title":"Viruses."},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108863","article-title":"Metabolic programs define dysfunctional immune responses in severe COVID-19 patients","volume":"34","author":"Thompson","year":"2021","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b0935","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0940","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.arcmed.2020.12.002","article-title":"Hypertension, diabetes and obesity, major risk factors for death in patients with COVID-19 in Mexico","volume":"52","author":"la Pe\u00f1a","year":"2021","journal-title":"Arch Med Res."},{"issue":"111685","key":"10.1016\/j.bcp.2021.114809_b0945","article-title":"COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies","volume":"140","author":"Hua","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.bcp.2021.114809_b0950","doi-asserted-by":"crossref","unstructured":"Marziliano A, Burns E, Chauhan L, Liu Y, Makhnevich A, Zhang M, et al. Patient factors and hospital outcomes associated with atypical presentation in hospitalized older adults with COVID-19 during the first surge of the pandemic. J Gerontol A Biol Sci Med Sci [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1093\/gerona\/glab171.","DOI":"10.1093\/gerona\/glab171"},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255544","article-title":"Risk factors for severity of COVID-19 in hospital patients age 18\u201329 years","volume":"16","author":"Sandoval","year":"2021","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b0960","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40123-020-00299-x","article-title":"Does COVID-19 involve the retina?","volume":"9","author":"Karampelas","year":"2020","journal-title":"Ophthalmol Ther."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b0965","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2352-4642(21)00198-X","article-title":"Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2","volume":"5","author":"Molteni","year":"2021","journal-title":"Lancet Child Adolesc Health."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b0970","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1016\/S2214-109X(21)00315-6","article-title":"Promoting evidence-informed cancer treatment policy making in sub-Saharan Africa","volume":"9","author":"Nonvignon","year":"2021","journal-title":"Lancet Glob Health."},{"key":"10.1016\/j.bcp.2021.114809_b0975","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semcancer.2019.07.007","article-title":"Revisiting the hallmarks of cancer: The role of hyaluronan","volume":"62","author":"Caon","year":"2020","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.bcp.2021.114809_b0980","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","author":"Faubert","year":"202036864875473","journal-title":"Science."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0985","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am J Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b0990","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"issue":"13","key":"10.1016\/j.bcp.2021.114809_b0995","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/cancers13133328","article-title":"Adipose tissue-derived extracellular vesicles and the tumor microenvironment: Revisiting the hallmarks of cancer","volume":"13","author":"Moraes","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"11","key":"10.1016\/j.bcp.2021.114809_b1000","first-page":"5789","article-title":"Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications","volume":"35","author":"Cazzaniga","year":"2015","journal-title":"Anticancer Res."},{"issue":"17","key":"10.1016\/j.bcp.2021.114809_b1005","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-20-0246","article-title":"Nitrogen trapping as a therapeutic strategy in tumors with mitochondrial dysfunction","volume":"80","author":"Madala","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2021.114809_b1010","doi-asserted-by":"crossref","unstructured":"Roy DG, Kaymak I, Williams KS, Ma EH, Jones RG. Immunometabolism in the tumor microenvironment. Annu Rev Cancer Biol [Internet]. 2021;5(1). Available from: http:\/\/dx.doi.org\/10.1146\/annurev-cancerbio-030518-055817.","DOI":"10.1146\/annurev-cancerbio-030518-055817"},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1015","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188534","article-title":"Mitochondria: The metabolic switch of cellular oncogenic transformation","volume":"1876","author":"Tan","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"10.1016\/j.bcp.2021.114809_b1025","first-page":"319","article-title":"\u00dcber den stoffwechsel der tumoren","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem Z"},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b1030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat Metab."},{"key":"10.1016\/j.bcp.2021.114809_b1040","doi-asserted-by":"crossref","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41577-021-00541-y.","DOI":"10.1038\/s41577-021-00541-y"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","article-title":"Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism","volume":"4","author":"Otto","year":"2016","journal-title":"Cancer Metab."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ddr.20342","article-title":"Lactic acid in cancer and mitochondrial disease","volume":"70","author":"Steliou","year":"2009","journal-title":"Drug Dev Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1055","first-page":"129","article-title":"Metabolic reprogramming, questioning, and implications for cancer","volume":"10","author":"Jacquet","year":"2021","journal-title":"Biology (Basel)."},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b1060","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cancers12051312","article-title":"Insight into the development of PET radiopharmaceuticals for oncology","volume":"12","author":"Lau","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bcp.2021.114809_b1065","doi-asserted-by":"crossref","unstructured":"Cai M, He J, Xiong J, Tay LWR, Wang Z, Rog C, et al. Phospholipase D1-regulated autophagy supplies free fatty acids to counter nutrient stress in cancer cells. Cell Death Dis. 2016;7(11):e2448\u2013e2448.","DOI":"10.1038\/cddis.2016.355"},{"issue":"114537","key":"10.1016\/j.bcp.2021.114809_b1070","article-title":"Mitochondria and the permeability transition pore in cancer metabolic reprogramming","volume":"188","author":"Guo","year":"2021","journal-title":"Biochem Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2021.148410","article-title":"Metabolic implications of non-electrogenic ATP\/ADP exchange in cancer cells: A mechanistic basis for the Warburg effect","volume":"1862","author":"Lemasters","year":"2021","journal-title":"Biochim Biophys Acta Bioenerg."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/endrev\/bnaa026","article-title":"Amino acid sensing in metabolic homeostasis and health","volume":"42","author":"Hu","year":"2021","journal-title":"Endocr Rev."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1085","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/ijms19071875","article-title":"FGF family: From drug development to clinical application","volume":"19","author":"Hui","year":"2018","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b1090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.canlet.2020.11.026","article-title":"FGF21 in obesity and cancer: New insights","volume":"499","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.bcp.2021.114809_b1095","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1158\/0008-5472.CAN-20-2153","article-title":"Metabolic enzyme DLST promotes tumor aggression and reveals a vulnerability to OXPHOS inhibition in high-risk neuroblastoma","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-016-0156-6","article-title":"Metabolic requirements for cancer cell proliferation","volume":"4","author":"Keibler","year":"2016","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bcp.2021.114809_b1105","doi-asserted-by":"crossref","unstructured":"Keibler MA, Dong W, Korthauer KD, Hosios AM, Moon SJ, Sullivan LB, et al. Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells. FEBS J [Internet]. 2021;(febs.15858). Available from: http:\/\/dx.doi.org\/10.1111\/febs.15858.","DOI":"10.1111\/febs.15858"},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b1110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"issue":"7873","key":"10.1016\/j.bcp.2021.114809_b1115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/d41586-021-02117-1","article-title":"A persistent look at how tumours evade therapy","volume":"596","author":"Gomez","year":"2021","journal-title":"Nature."},{"issue":"7873","key":"10.1016\/j.bcp.2021.114809_b1120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2021.114809_b1125","doi-asserted-by":"crossref","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41575-021-00486-6.","DOI":"10.1038\/s41575-021-00486-6"},{"issue":"29","key":"10.1016\/j.bcp.2021.114809_b1130","doi-asserted-by":"crossref","first-page":"11191","DOI":"10.1021\/jacs.1c05103","article-title":"Single-cell profiling of fatty acid uptake using surface-immobilized dendrimers","volume":"143","author":"Guo","year":"2021","journal-title":"J Am Chem Soc."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ccell.2021.06.016","article-title":"Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP\/TEAD activity","volume":"39","author":"Pearson","year":"2021","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118893","article-title":"Copper metabolism as a unique vulnerability in cancer","volume":"1868","author":"Shanbhag","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"issue":"38","key":"10.1016\/j.bcp.2021.114809_b1145","doi-asserted-by":"crossref","first-page":"62726","DOI":"10.18632\/oncotarget.10911","article-title":"Oncogenic regulation of tumor metabolic reprogramming","volume":"7","author":"Tarrado-Castellarnau","year":"2016","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b1150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2020.11.014","article-title":"Capitalizing on synthetic lethality of MYC to treat cancer in the digital age","volume":"42","author":"Thng","year":"2021","journal-title":"Trends Pharmacol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b1155","doi-asserted-by":"crossref","unstructured":"Whitfield JR, Soucek L. The long journey to bring a Myc inhibitor to the clinic. J Cell Biol [Internet]. 2021;220(8). Available from: http:\/\/dx.doi.org\/10.1083\/jcb.202103090.","DOI":"10.1083\/jcb.202103090"},{"key":"10.1016\/j.bcp.2021.114809_b1160","doi-asserted-by":"crossref","unstructured":"Zhao H, Li Y. Cancer metabolism and intervention therapy. Mol Biomed [Internet]. 2021;2(1). Available from: http:\/\/dx.doi.org\/10.1186\/s43556-020-00012-1.","DOI":"10.1186\/s43556-020-00012-1"},{"issue":"5","key":"10.1016\/j.bcp.2021.114809_b1165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2021.114809_b1170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.copbio.2020.10.011","article-title":"Metabolic traits ruling the specificity of the immune response in different cancer types","volume":"68","author":"Flerin","year":"2021","journal-title":"Curr Opin Biotechnol."},{"key":"10.1016\/j.bcp.2021.114809_b1175","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-20-1723","article-title":"Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages","author":"Hinshaw","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b1180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.bcp.2021.114809_b1185","doi-asserted-by":"crossref","unstructured":"Monferrer E, Vieco-Mart\u00ed I, L\u00f3pez-Carrasco A, Fari\u00f1as F, Abanades S, de la Cruz-Merino L, et al. Metabolic classification and intervention opportunities for tumor energy dysfunction. Metabolites [Internet]. 2021;11(5). Available from: http:\/\/dx.doi.org\/10.3390\/metabo11050264.","DOI":"10.3390\/metabo11050264"},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1190","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/cancers13040904","article-title":"Metabolism of innate immune cells in cancer","volume":"13","author":"Talty","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1195","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cac2.12182","article-title":"Metabolic regulation in the immune response to cancer","volume":"41","author":"Wu","year":"2021","journal-title":"Cancer Commun (Lond)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b1205","article-title":"T cell metabolism in cancer immunotherapy","volume":"2","author":"Aksoylar","year":"2020","journal-title":"Immunometabolism [Internet]."},{"issue":"9","key":"10.1016\/j.bcp.2021.114809_b1210","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1002\/jcp.30303","article-title":"Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer","volume":"236","author":"Aria","year":"2021","journal-title":"J Cell Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165845","article-title":"Mitochondrial function in immune cells in health and disease","volume":"1866","author":"Faas","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"664","key":"10.1016\/j.bcp.2021.114809_b1220","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abc4436","article-title":"Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer","volume":"14","author":"Crooks","year":"2021","journal-title":"Sci Signal."},{"issue":"18","key":"10.1016\/j.bcp.2021.114809_b1225","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1002\/cam4.4190","article-title":"PD-1\/PD-L1 inhibitors-based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies","volume":"10","author":"Ding","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2019.12.002","article-title":"Reprogramming of metabolism in kidney cancer","volume":"40","author":"Wettersten","year":"2020","journal-title":"Semin Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188559","article-title":"Metabolic reprogramming in renal cancer: Events of a metabolic disease","volume":"1876","author":"Chakraborty","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"10.1016\/j.bcp.2021.114809_b1240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cancergen.2021.03.005","article-title":"Determination of the key ccRCC-related molecules from monolayer network to three-layer network","volume":"256\u2013257","author":"Wu","year":"2021","journal-title":"Cancer Genet."},{"key":"10.1016\/j.bcp.2021.114809_b1245","doi-asserted-by":"crossref","unstructured":"Sullivan RJ, Weber JS. Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies. Nat Rev Drug Discov [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1038\/s41573-021-00259-5.","DOI":"10.1038\/s41573-021-00259-5"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-pharmtox-010919-023451","article-title":"Immune checkpoint inhibitor cardiotoxicity: Understanding basic mechanisms and clinical characteristics and finding a cure","volume":"61","author":"Waliany","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1016\/j.bcp.2021.114809_b1255","doi-asserted-by":"crossref","unstructured":"Ahn R, Ursini-Siegel J. Clinical potential of kinase inhibitors in combination with immune checkpoint inhibitors for the treatment of solid tumors. Int J Mol Sci [Internet]. 2021;22(5). Available from: http:\/\/dx.doi.org\/10.3390\/ijms22052608.","DOI":"10.3390\/ijms22052608"},{"issue":"109958","key":"10.1016\/j.bcp.2021.114809_b1260","article-title":"Review on combination strategy of immune checkpoint blockade, photodynamic therapy and nanomedicine against solid tumor","volume":"209","author":"Li","year":"2021","journal-title":"Mater Des."},{"key":"10.1016\/j.bcp.2021.114809_b1265","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2021.04.021","article-title":"Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy","volume":"511","author":"Wei","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2021.114809_b1270","doi-asserted-by":"crossref","unstructured":"Zambrana F, Carril-Ajuria L, G\u00f3mez de Lia\u00f1o A, Martinez Chanza N, Manneh R, Castellano D, et al. Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news. Cancer Treat Rev. 2021;99(102239):102239.","DOI":"10.1016\/j.ctrv.2021.102239"},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12915-021-01092-3","article-title":"So many ways to naturally kill a cancer cell","volume":"19","author":"Mitchison","year":"2021","journal-title":"BMC Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/onco.13682","article-title":"Pembrolizumab in patients with advanced metastatic germ cell tumors","volume":"26","author":"Tsimberidou","year":"2021","journal-title":"Oncologist."},{"issue":"102228","key":"10.1016\/j.bcp.2021.114809_b1295","article-title":"Checkpoint inhibitors in metastatic papillary renal cell carcinoma","volume":"99","author":"de Vries-Brilland","year":"2021","journal-title":"Cancer Treat Rev."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b1300","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/CIRCRESAHA.121.318223","article-title":"Heart failure with targeted cancer therapies: Mechanisms and cardioprotection: Mechanisms and cardioprotection","volume":"128","author":"Hahn","year":"2021","journal-title":"Circ Res."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1305","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMe2109354","article-title":"The promise of adjuvant immunotherapy in renal-cell carcinoma","volume":"385","author":"McKay","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bcp.2021.114809_b1310","unstructured":"FDA approves KEYTRUDA\u00ae (pembrolizumab) plus LENVIMA\u00ae (lenvatinib) combination for first-line treatment of adult patients with advanced renal cell carcinoma (RCC) [Internet]. Bwnews.pr. 2021 [cited 2021 Oct 4]. Available from: https:\/\/bwnews.pr\/3m0p3Vh."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b1315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","article-title":"Genetic and non-genetic clonal diversity in cancer evolution","volume":"21","author":"Black","year":"2021","journal-title":"Nat Rev Cancer."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b1320","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3390\/cancers13123083","article-title":"Response prediction and evaluation using PET in patients with solid tumors treated with immunotherapy","volume":"13","author":"Borm","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/ph14070677","article-title":"Hacking pancreatic cancer: Present and future of personalized medicine","volume":"14","author":"Di Federico","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41746-021-00381-z","article-title":"DeePaN: deep patient graph convolutional network integrating clinico-genomic evidence to stratify lung cancers for immunotherapy","volume":"4","author":"Fang","year":"2021","journal-title":"NPJ Digit Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1335","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1080\/21645515.2021.1891817","article-title":"Strategies to sensitize cancer cells to immunotherapy","volume":"17","author":"George","year":"2021","journal-title":"Hum Vaccin Immunother."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13073-018-0598-2","article-title":"Acquired mechanisms of immune escape in cancer following immunotherapy","volume":"10","author":"Iorgulescu","year":"2018","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21037\/atm-20-1076","article-title":"Immune profiling and immunotherapeutic targets in pancreatic cancer","volume":"9","author":"Lenzo","year":"2021","journal-title":"Ann Transl Med."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1350","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1355","first-page":"51","article-title":"Criteria of metabolic response to immunotherapy","volume":"39","author":"Rasilla","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/onco1010002","article-title":"The impact of immune checkpoint-inhibitors therapy in urinary bladder cancer","volume":"1","author":"Silva","year":"2021","journal-title":"Onco."},{"key":"10.1016\/j.bcp.2021.114809_b1365","article-title":"Peripheral blood autoantibodies against to tumor-associated antigen predict clinical outcome to immune checkpoint inhibitor-based treatment in advanced non-small cell lung cancer","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.bcp.2021.114809_b1370","doi-asserted-by":"crossref","unstructured":"Gulati S, Vogelzang NJ. Biomarkers in renal cell carcinoma: Are we there yet? Asian J Urol [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1016\/j.ajur.2021.05.013.","DOI":"10.1016\/j.ajur.2021.05.013"},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1375","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cbin.11506","article-title":"Redox tolerance and metabolic reprogramming in solid tumors","volume":"45","author":"Mortezaee","year":"2021","journal-title":"Cell Biol Int."},{"issue":"575","key":"10.1016\/j.bcp.2021.114809_b1380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba6110","article-title":"Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer","volume":"13","author":"Oresta","year":"2021","journal-title":"Sci Transl Med."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00335-021-09867-3","article-title":"A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer","volume":"32","author":"Kim","year":"2021","journal-title":"Mamm Genome."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1390","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ijc.33524","article-title":"Role of gut microbiome in the outcome of cancer immunotherapy","volume":"149","author":"Ma","year":"2021","journal-title":"Int J Cancer."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1395","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","article-title":"Cancer and the microbiome-influence of the commensal Microbiota on cancer, immune responses, and immunotherapy","volume":"160","author":"Matson","year":"2021","journal-title":"Gastroenterology."},{"key":"10.1016\/j.bcp.2021.114809_b1400","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.semcancer.2021.05.008","article-title":"The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era","volume":"73","author":"Spyrou","year":"2021","journal-title":"Semin Cancer Biol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1405","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s43587-021-00080-0","article-title":"The economic value of targeting aging","volume":"1","author":"Scott","year":"2021","journal-title":"Nat Aging."},{"issue":"111344","key":"10.1016\/j.bcp.2021.114809_b1410","article-title":"What if there\u2019s no such thing as \u201caging\u201d?","volume":"192","author":"Cohen","year":"2020","journal-title":"Mech Ageing Dev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1415","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10522-021-09926-x","article-title":"An essay on the nominal vs. real definitions of aging","volume":"22","author":"Golubev","year":"2021","journal-title":"Biogerontology."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2021.114809_b1420","article-title":"Aging biomarkers: From functional tests to multi-omics approaches","volume":"20","author":"Kudryashova","year":"2020","journal-title":"Proteomics."},{"issue":"15","key":"10.1016\/j.bcp.2021.114809_b1425","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/1873-3468.13802","article-title":"Mitochondrial turnover and homeostasis in ageing and neurodegeneration","volume":"594","author":"Markaki","year":"2020","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bcp.2021.114809_b1430","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s43587-021-00082-y","article-title":"An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging","volume":"1","author":"Sayed","year":"2021","journal-title":"Nat Aging."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1435","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.3390\/ijms22084137","article-title":"Cardio- and neurometabolic adipobiology: Consequences and implications for therapy","volume":"22","author":"Frohlich","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2021.114809_b1440","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2021.03.045","article-title":"Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases","volume":"169","author":"Bartekov\u00e1","year":"2021","journal-title":"Free Radic Biol Med."},{"issue":"6556","key":"10.1016\/j.bcp.2021.114809_b1445","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.abe5017","article-title":"Daily energy expenditure through the human life course","volume":"373","author":"Pontzer","year":"2021","journal-title":"Science."},{"issue":"6556","key":"10.1016\/j.bcp.2021.114809_b1450","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.abl4537","article-title":"Taking the long view on metabolism","volume":"373","author":"Rhoads","year":"2021","journal-title":"Science."},{"issue":"15","key":"10.1016\/j.bcp.2021.114809_b1455","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acschemneuro.1c00295","article-title":"APOE genotype and Alzheimer\u2019s disease: The influence of lifestyle and environmental factors","volume":"12","author":"Angelopoulou","year":"2021","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.bcp.2021.114809_b1460","doi-asserted-by":"crossref","unstructured":"Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL Jr, Darley-Usmar V, et al. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer\u2019s disease. Acta Pharm Sin B [Internet]. 2021; Available from: http:\/\/dx.doi.org\/10.1016\/j.apsb.2021.06.014.","DOI":"10.1016\/j.apsb.2021.06.014"},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b1465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ddr.21294","article-title":"Epigenetic treatment of neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"77","author":"Irwin","year":"2016","journal-title":"Drug Dev Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/biores.2018.0017","article-title":"A new approach to treating neurodegenerative otologic disorders","volume":"7","author":"Moos","year":"2018","journal-title":"Biores Open Access."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ddr.21295","article-title":"Epigenetic treatment of neuropsychiatric disorders: Autism and schizophrenia: Epigenetic treatment of neuropsychiatric disorders","volume":"77","author":"Moos","year":"2016","journal-title":"Drug Dev Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1480","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/biores.2017.0020","article-title":"Gut Microbiota and salivary diagnostics: The mouth is salivating to tell us something","volume":"6","author":"Kodukula","year":"2017","journal-title":"Biores Open Access."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1485","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/diagnostics11020371","article-title":"The role of salivary biomarkers in the early diagnosis of Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Pawlik","year":"2021","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.bcp.2021.114809_b1490","article-title":"Advances of mechanisms-related metabolomics in Parkinson\u2019s disease","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1495","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","article-title":"Cardiolipin, mitochondria, and neurological disease","volume":"32","author":"Falabella","year":"2021","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114809_b1500","article-title":"Aging delay: of mice and men","volume":"92","author":"Anisimov","year":"2021","journal-title":"Acta Biomed."},{"issue":"3","key":"10.1016\/j.bcp.2021.114809_b1505","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaophthalmol.2020.6331","article-title":"Association of metformin use with age-related macular degeneration: A case-control study: A case-control study","volume":"139","author":"Blitzer","year":"2021","journal-title":"JAMA Ophthalmol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114809_b1510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234571","article-title":"Determination of metformin bio-distribution by LC-MS\/MS in mice treated with a clinically relevant paradigm","volume":"15","author":"Chaudhari","year":"2020","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1515","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12765","article-title":"Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7","volume":"17","author":"Fang","year":"2018","journal-title":"Aging Cell."},{"issue":"113378","key":"10.1016\/j.bcp.2021.114809_b1520","article-title":"Biguanides: Species with versatile therapeutic applications","volume":"219","author":"Kathuria","year":"2021","journal-title":"Eur J Med Chem."},{"issue":"111286","key":"10.1016\/j.bcp.2021.114809_b1525","article-title":"The effects of metformin on autophagy","volume":"137","author":"Lu","year":"2021","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1530","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40123-021-00344-3","article-title":"Metformin, A potential role in age-related macular degeneration: A systematic review and meta-analysis","volume":"10","author":"Romdhoniyyah","year":"2021","journal-title":"Ophthalmol Ther."},{"issue":"119343","key":"10.1016\/j.bcp.2021.114809_b1535","article-title":"Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke","volume":"274","author":"Sharma","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114809_b1540","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ddr.21636","article-title":"A review of phenformin, metformin, and imeglimin","volume":"81","author":"Yendapally","year":"2020","journal-title":"Drug Dev Res."},{"key":"10.1016\/j.bcp.2021.114809_b1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110313","article-title":"Antiaging compounds from marine organisms","volume":"143","author":"Wang","year":"2021","journal-title":"Food Res Int."},{"issue":"47","key":"10.1016\/j.bcp.2021.114809_b1550","doi-asserted-by":"crossref","first-page":"23505","DOI":"10.1073\/pnas.1910073116","article-title":"A single combination gene therapy treats multiple age-related diseases","volume":"116","author":"Davidsohn","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bcp.2021.114809_b1555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exger.2019.01.001","article-title":"Impact of aging and caloric restriction on fibroblast growth factor 21 signaling in rat white adipose tissue","volume":"118","author":"Fujii","year":"2019","journal-title":"Exp Gerontol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114809_b1560","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/nm.4005","article-title":"Can aging be \u201cdrugged\u201d?","volume":"21","author":"Riera","year":"2015","journal-title":"Nat Med."},{"key":"10.1016\/j.bcp.2021.114809_b1565","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.655575","article-title":"The roles and pharmacological effects of FGF21 in preventing aging-associated metabolic diseases","volume":"8","author":"Yan","year":"2021","journal-title":"Front Cardiovasc Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114809_b1570","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41573-020-0067-7","article-title":"The quest to slow ageing through drug discovery","volume":"19","author":"Partridge","year":"2020","journal-title":"Nat Rev Drug Discov."},{"issue":"10","key":"10.1016\/j.bcp.2021.114809_b1575","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13230","article-title":"COVID-19 is an emergent disease of aging","volume":"19","author":"Santesmasses","year":"2020","journal-title":"Aging Cell."},{"issue":"7821","key":"10.1016\/j.bcp.2021.114809_b1580","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2021.114809_b1585","article-title":"Mediterranean Diet and cardiovascular health: an historical perspective","volume":"1\u201314","author":"Delarue","year":"2021","journal-title":"Br J Nutr."},{"key":"10.1016\/j.bcp.2021.114809_b1590","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tifs.2021.07.037","article-title":"Korean traditional foods as antiviral and respiratory disease prevention and treatments: A detailed review","volume":"116","author":"Das","year":"2021","journal-title":"Trends Food Sci Technol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114809_b1595","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5455\/AAM.111288","article-title":"Prevention of metabolic risks by Kalabhojanam strategy of Ayurveda","volume":"9","author":"Prakash","year":"2020","journal-title":"Ann Ayurvedic Med."},{"issue":"16","key":"10.1016\/j.bcp.2021.114809_b1600","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","article-title":"Gut-microbiota-targeted diets modulate human immune status","volume":"184","author":"Wastyk","year":"2021","journal-title":"Cell."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:10:33Z","timestamp":1762096233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":320,"alternative-id":["S0006295221004251"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114809","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic mitochondrial dysfunction and metabolic abnormalities","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114809"}}